Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII.
- 19 July 1994
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 91 (15) , 7296-7300
- https://doi.org/10.1073/pnas.91.15.7296
Abstract
Mechanical stability in many biological materials is provided by the crosslinking of large structural proteins with gamma-glutamyl-epsilon-lysyl amide bonds. The three-dimensional structure of human recombinant factor XIII (EC 2.3.2.13 zymogen; protein-glutamine:amine gamma-glutamyltransferase a chain), a transglutaminase zymogen, has been solved at 2.8-A resolution by x-ray crystallography. This structure shows that each chain of the homodimeric protein is folded into four sequential domains. A catalytic triad reminiscent of that observed in cysteine proteases has been identified in the core domain. The amino-terminal activation peptide of each subunit crosses the dimer interface and partially occludes the opening of the catalytic cavity in the second subunit, preventing substrate binding to the zymogen. A proposal for the mechanism of activation by thrombin and calcium is made that details the structural events leading to active factor XIIIa'.Keywords
This publication has 41 references indexed in Scilit:
- Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complexJournal of Molecular Biology, 1992
- Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritisArthritis & Rheumatism, 1991
- Substitution of Factor XIII: A Therapeutic Approach to Ulcerative ColitisPathophysiology of Haemostasis and Thrombosis, 1991
- Blood coagulation factor XIII contributes to the development of traction retinal detachmentActa Ophthalmologica, 1990
- Vitronectin is a substrate for transglutaminasesBiochemical and Biophysical Research Communications, 1988
- Thrombospondin is a substrate for blood coagulation factor XIIIaBiochemistry, 1986
- Plasma Factor XIII and some other Haemostasis Parameters in Patients with Diabetic AngiopathyActa Haematologica, 1986
- A Contribution to the Pathology of Acquired Plasma Factor XIII DeficiencySeminars in Thrombosis and Hemostasis, 1985
- Mechanism and BASIS for Specificity of Transglutaminase‐Catalyzed ε‐(γ‐Glutamyl) Lysine Bond FormationPublished by Wiley ,1983
- Inhibitors of Fibrin Cross-linking : Relevance for ThrombolysisNature, 1966